Edgewise Therapeutics Inc Earnings

Edgewise Therapeutics Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Edgewise Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Edgewise Therapeutics Inc’s net profit fell -26.61% since last year same period to $-50.22Mn in the Q4 2025. On a quarterly growth basis, Edgewise Therapeutics Inc has generated -23.48% fall in its net profits since last 3-months.

Edgewise Therapeutics Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Edgewise Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Edgewise Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a -1.61% fall from last quarter’s estimates.

Edgewise Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.44.

Edgewise Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Edgewise Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.